Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: April 16, 2012
Last updated: February 7, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)